{"url_path":"/sec/acmr/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1680062/0001628280-26-032842-index.html","accession_number":"0001628280-26-032842","cik":"0001680062","ticker":"ACMR","issuer_name":"ACM Research, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1680062/0001628280-26-032842-index.html","primary_entity_key":"0001680062","primary_entity_name":"ACM Research, Inc."},"word_count":109,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nOn March 5, 2026, Sotheara Cheav, an executive officer, adopted a Rule 10b5-1 trading arrangement (the \"Cheav Plan\") that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Cheav Plan allows for the contemporaneous exercise of options and sale of up to 18,750 shares of Class A Common Stock, at specific market prices, commencing on June 4, 2026, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii) June 1, 2027, or (iii) such date that the Cheav Plan is otherwise terminated according to its terms, whichever comes first.\n\n39\n\n[Table of Contents](#i8ac3ef1aa2ff43228dbbf1f9b4e12831_7)"}